Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 6 |
GO:0042995 | cell projection | 2 | 6 |
GO:0043226 | organelle | 2 | 6 |
GO:0043227 | membrane-bounded organelle | 3 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 6 |
Related structures:
AlphaFold database: E9B5D7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 52 | 56 | PF00656 | 0.446 |
CLV_NRD_NRD_1 | 16 | 18 | PF00675 | 0.569 |
CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.561 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.409 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.569 |
CLV_PCSK_KEX2_1 | 216 | 218 | PF00082 | 0.561 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.409 |
CLV_PCSK_PC7_1 | 12 | 18 | PF00082 | 0.572 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.575 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 96 | 100 | PF00082 | 0.452 |
DOC_CYCLIN_RxL_1 | 114 | 124 | PF00134 | 0.471 |
DOC_CYCLIN_RxL_1 | 9 | 18 | PF00134 | 0.580 |
DOC_MAPK_MEF2A_6 | 128 | 136 | PF00069 | 0.406 |
DOC_PP1_RVXF_1 | 115 | 122 | PF00149 | 0.455 |
DOC_PP1_RVXF_1 | 126 | 132 | PF00149 | 0.388 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.480 |
DOC_USP7_MATH_1 | 233 | 237 | PF00917 | 0.724 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.446 |
DOC_WW_Pin1_4 | 227 | 232 | PF00397 | 0.585 |
DOC_WW_Pin1_4 | 35 | 40 | PF00397 | 0.505 |
LIG_14-3-3_CanoR_1 | 16 | 26 | PF00244 | 0.565 |
LIG_14-3-3_CanoR_1 | 192 | 198 | PF00244 | 0.461 |
LIG_14-3-3_CanoR_1 | 66 | 72 | PF00244 | 0.475 |
LIG_14-3-3_CanoR_1 | 77 | 86 | PF00244 | 0.351 |
LIG_14-3-3_CanoR_1 | 96 | 101 | PF00244 | 0.334 |
LIG_Actin_WH2_2 | 38 | 56 | PF00022 | 0.371 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.628 |
LIG_BRCT_BRCA1_1 | 19 | 23 | PF00533 | 0.501 |
LIG_CSL_BTD_1 | 130 | 133 | PF09270 | 0.404 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.471 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.585 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.644 |
LIG_LIR_Gen_1 | 95 | 105 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 20 | 26 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 73 | 78 | PF02991 | 0.443 |
LIG_LIR_Nem_3 | 95 | 100 | PF02991 | 0.399 |
LIG_NRBOX | 157 | 163 | PF00104 | 0.408 |
LIG_Pex14_1 | 131 | 135 | PF04695 | 0.394 |
LIG_SH2_CRK | 43 | 47 | PF00017 | 0.410 |
LIG_SH2_CRK | 97 | 101 | PF00017 | 0.357 |
LIG_SH2_NCK_1 | 97 | 101 | PF00017 | 0.390 |
LIG_SH2_PTP2 | 50 | 53 | PF00017 | 0.431 |
LIG_SH2_STAP1 | 43 | 47 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.470 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.284 |
LIG_SH3_3 | 36 | 42 | PF00018 | 0.506 |
LIG_SUMO_SIM_anti_2 | 155 | 163 | PF11976 | 0.413 |
LIG_SUMO_SIM_par_1 | 23 | 29 | PF11976 | 0.599 |
LIG_TRAF2_1 | 2 | 5 | PF00917 | 0.656 |
LIG_TYR_ITIM | 41 | 46 | PF00017 | 0.460 |
LIG_TYR_ITSM | 93 | 100 | PF00017 | 0.371 |
LIG_UBA3_1 | 190 | 195 | PF00899 | 0.382 |
MOD_CK1_1 | 148 | 154 | PF00069 | 0.342 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.446 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.483 |
MOD_GlcNHglycan | 176 | 180 | PF01048 | 0.539 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.550 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.484 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.439 |
MOD_GSK3_1 | 229 | 236 | PF00069 | 0.747 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.306 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.366 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.449 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.558 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.377 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.338 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.273 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.388 |
MOD_PIKK_1 | 148 | 154 | PF00454 | 0.359 |
MOD_PIKK_1 | 198 | 204 | PF00454 | 0.446 |
MOD_PKA_2 | 15 | 21 | PF00069 | 0.558 |
MOD_PKA_2 | 65 | 71 | PF00069 | 0.488 |
MOD_Plk_1 | 8 | 14 | PF00069 | 0.464 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.543 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.443 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.441 |
MOD_ProDKin_1 | 227 | 233 | PF00069 | 0.592 |
MOD_ProDKin_1 | 35 | 41 | PF00069 | 0.487 |
TRG_DiLeu_BaEn_1 | 9 | 14 | PF01217 | 0.467 |
TRG_DiLeu_BaLyEn_6 | 21 | 26 | PF01217 | 0.499 |
TRG_DiLeu_LyEn_5 | 9 | 14 | PF01217 | 0.467 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.453 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.431 |
TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.443 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.438 |
TRG_ER_diArg_1 | 15 | 17 | PF00400 | 0.572 |
TRG_ER_diArg_1 | 216 | 218 | PF00400 | 0.476 |
TRG_ER_diArg_1 | 47 | 49 | PF00400 | 0.425 |
TRG_NES_CRM1_1 | 59 | 73 | PF08389 | 0.350 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7X8B4 | Leishmania donovani | 91% | 100% |
A4HB66 | Leishmania braziliensis | 76% | 100% |
A4IAB4 | Leishmania infantum | 91% | 100% |
Q4Q2J6 | Leishmania major | 89% | 100% |